Streetbeat News

Stock Prices

TLRY

Tilray Medical, a division of Tilray Brands, Inc., announced a study showing that cannabinoid treatment significantly reduces fibromyalgia pain and improves quality of life. The study highlights the potential of cannabinoids as a cost-effective treatment option.

Portfolio Pulse from Jelena Martinovic

September 09, 2024 | 1:50 pm

ASML

Options trading for ASML Holding shows a bearish sentiment among large investors, with 58% of trades being bearish. The price range targeted by these trades is between $510 and $1140. ASML's stock is currently up 1.07% at $760.84, with RSI indicators suggesting it may be oversold.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 1:46 pm

NFLX

Financial giants are showing a bullish trend on Netflix (NASDAQ:NFLX) with 66% of options trades being bullish. Analysts have set high price targets, and the stock is currently up 1.18% at $673.6. The next earnings report is expected in 37 days.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 1:46 pm

AMD

Deep-pocketed investors are showing a bullish sentiment towards Advanced Micro Devices (AMD) through significant options activity. Benzinga's options scanner highlighted 13 extraordinary options activities, with a mix of bullish and bearish sentiments. The price window eyed by these investors ranges from $95 to $160. AMD's stock is currently trading at $135.68, up by 0.99%.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 1:46 pm

GSK

GSK presented late-breaking data at the ERS showing that their drug Depemokimab significantly reduces severe asthma exacerbations by 54% in Phase III trials. The SWIFT-1 and SWIFT-2 studies demonstrated meaningful reductions over 52 weeks compared to placebo.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:38 pm

PI

Impinj shares are rising following the announcement that the company will be added to the S&P SmallCap 600 index.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:36 pm

INSP

Inspire Medical Systems shares rose following the announcement of its inclusion in the SmallCap 600 index.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:35 pm

ADMA

ADMA Biologics shares rose following the announcement that the company will be added to the S&P SmallCap 600 index.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:34 pm

HALB

Halberd Corp. has issued a letter to shareholders discussing the evolving PTSD market and their innovative solutions, including the WatchDawg and LDX medication combination. The company highlights advancements in PTSD treatment, government support, and the integration of mental health services. They emphasize their wearable technology for real-time health monitoring and the potential for franchising their WatchDawg business model. Halberd is pursuing FDA Fast Track designation for their LDX solution and exploring Breakthrough Therapy designation.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:33 pm

GNPX

Genprex, Inc. announced that its collaborators will present preclinical data on Reqorsa Gene Therapy at the 2024 EORTC-NCI-AACR Symposium. The data focuses on treating Ras inhibitor resistant lung cancer, mesothelioma, and glioblastoma.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:33 pm